IP Library Granted Patent US 7,419,597
Granted Patent B2
US 7,419,597 · App. 11/695,739 · Granted Sep 2, 2008

Fluid, circuits, systems, and processes for extracorporeal blood processing

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,419,597
App. No.
11/695,739
Granted
Sep 2, 2008
Kind
B2
Abstract

A method for renal replacement therapy includes priming a fluid circuit and recirculating the sterile fluid during priming to permit gas to float out of the sterile fluid into a fluid reservoir. The fluid is preferably either warmed during circulation or vibrated to promote the removal of gas.

Claims (16)

1. A method for performing renal replacement therapy with a treatment device that employs a fluid circuit with liquid and blood fluid circuits separated by a membrane, the membrane having a pore size effective to block the passage of pyrogenic material, the method comprising: connecting a source of electrolytically-balanced fluid to the liquid fluid circuit; ensuring sterility of the electrolytically-balanced fluid by passing the same through the membrane to produce sterile fluid and storing the sterile fluid in a reservoir; warming and maintaining a temperature of the sterile fluid until a treatment time; recirculating the sterile fluid through the reservoir to permit gas to be purged from the sterile fluid by permitting gas to be floated out of the sterile fluid in the reservoir and prime a portion of the fluid circuit; priming a further portion of the fluid circuit.

2. A method as in claim 1 , wherein the priming a further portion is executed after the recirculating.

3. A method as in claim 1 , further comprising conveying blood from a patient through the blood fluid circuit during a treatment cycle and removing waste from the blood from the blood circuit through the membrane to the liquid fluid circuit.

4. A method as in claim 1 , further comprising using the sterile fluid from reservoir in the process of performing a blood waste removing process on a patient.

5. A method as in claim 1 , wherein the ensuring sterility includes ensuring a rate of endotoxins below a predetermined level by filtering with a membrane with a pore size effective to limit endotoxins.

6. A method as in claim 5 , wherein the predetermined level is 3 EUs/ml. or less.

7. A method as in claim 1 , further comprising vibrating the reservoir to aid in the removal of gas.

8. A method as in claim 1 wherein the passing the electrolytically-balanced fluid includes operating a blood pump in a first direction, the method further including conveying blood through the fluid circuit at the treatment time, the conveying blood including operating the blood pump in a second direction opposite the first direction.

9. A method for performing renal replacement therapy with a treatment device that employs a fluid circuit with liquid and blood fluid circuits separated by a membrane, the method comprising: connecting a source of electrolytically-balanced fluid to the liquid fluid circuit; passing the electrolytically-balanced fluid through the membrane and storing the resulting sterile fluid in a reservoir; warming the sterile fluid prior to a treatment time; and recirculating the sterile fluid through the reservoir to permit gas to be purged from the sterile fluid and prime at least a portion of the fluid by permitting gas to be floated out of the sterile fluid in the reservoir circuit.

10. A method as in claim 9 , further comprising priming a further portion of the fluid circuit after recirculating the sterile fluid through the reservoir.

11. A method as in claim 9 , further comprising conveying blood from a patient through the blood fluid circuit during a treatment cycle and removing waste from the blood from the blood circuit through the membrane to the liquid fluid circuit.

12. A method as in claim 9 , further comprising using the sterile fluid from reservoir in the process of performing a blood waste removing process on a patient.

13. A method as in claim 9 , wherein the passing the electrolytically-balanced fluid through the membrane includes providing a rate of endotoxins below a predetermined level by filtering with a membrane with a pore size effective to limit endotoxins.

14. A method as in claim 13 , wherein the predetermined level is 3 EUs/ml. or less.

15. A method as in claim 9 , further comprising vibrating the reservoir to aid in the removal of gas.

16. A method as in claim 9 wherein the passing the electrolytically-balanced fluid includes operating a blood pump in a first direction, the method further including conveying blood through the fluid circuit at the treatment time, the conveying blood including operating the blood pump in a second direction opposite the first direction.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Feb 21, 2019
From: CAPITAL ONE, NATIONAL ASSOCIATION (AS SUCCESSOR BY MERGER TO HEALTHCARE FINANCIAL SOLUTIONS, LLC)
To: NXSTAGE MEDICAL, INC.
Reel/Frame 048407/0865 →
RELEASE OF SECURITY INTEREST Recorded Jul 28, 2017
From: ASAHI KASEI MEDICAL CO., LTD. F/K/A ASAHI KASEI KURARAY MEDICAL CO., LTD.
To: NXSTAGE MEDICAL, INC.; MEDISYSTEMS CORPORATION; MEDISYSTEMS SERVICES CORPORATION
Reel/Frame 043364/0936 →
ASSIGNMENT OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Nov 16, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS RETIRING AGENT
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT
Reel/Frame 037112/0376 →
RELEASE OF SECURITY INTEREST Recorded Jun 11, 2014
From: SILICON VALLEY BANK
To: NXSTAGE MEDICAL, INC.
Reel/Frame 033133/0902 →
SECURITY INTEREST Recorded Jun 10, 2014
From: NXSTAGE MEDICAL, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 033123/0836 →
SECURITY AGREEMENT Recorded Mar 22, 2010
From: NXSTAGE MEDICAL, INC.
To: SILICON VALLEY BANK
Reel/Frame 024114/0789 →
RELEASE OF SECURITY INTEREST Recorded Jun 10, 2009
From: GE BUSINESS FINANCIAL SERVICES INC.
To: NXSTAGE MEDICAL, INC.; EIR MEDICAL, INC.; MEDISYSTEMS CORPORATION; MEDISYSTEMS SERVICES CORPORATION
Reel/Frame 022804/0150 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jun 10, 2009
From: NXSTAGE MEDICAL, INC.; EIR MEDICAL, INC.; MEDISYSTEMS CORPORATION; MEDISYSTEMS SERVICES CORPORATION
To: ASAHI KASEI KURARAY MEDICAL CO., LTD.
Reel/Frame 022804/0496 →
SECURITY AGREEMENT Recorded Apr 7, 2009
From: NXSTAGE MEDICAL, INC.; EIR MEDICAL, INC.; MEDISYSTEMS CORPORATION; MEDISYSTEMS SERVICES CORPORATION
To: GE BUSINESS FINANCIAL SERVICES INC.
Reel/Frame 022610/0602 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 15, 2007
From: BRUGGER, JAMES M; BURBANK, JEFFREY H; TREU, DENNIS M
To: NXSTAGE MEDICAL, INC.
Reel/Frame 020118/0708 →